MAP2K7 and neoplasm: In the present study, CH5126766 caused regression of tumor without apparent apoptosis in vitro, which was consistent with the clinical data that RAF or MEK inhibitors showed quite good response rate reflecting regression of advanced melanoma (4, 6, 7).